E. Cho

Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell carcinoma

Y. Shim, Y. Im, S. Lee, 2010, British Journal of Cancer.

Clinical significance of CD151 overexpression in subtypes of invasive breast cancer

Y. Im, Y. Shin, S. Nam, 2012, British Journal of Cancer.

Evaluation of ER and Ki-67 proliferation index as prognostic factors for survival following neoadjuvant chemotherapy with doxorubicin/docetaxel for locally advanced breast cancer

J. Ahn, J. Kim, Y. Im, 2008, Cancer Chemotherapy and Pharmacology.

Clinical relevance of TNM staging system according to breast cancer subtypes.

Y. Im, S. Nam, B. Han, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Heterogeneity of Triple Negative Breast Cancer (TNBC): TNBC Might Be Divided into Two or More Subgroups by Clinicopathologic Findings.

Jung-Hyun Yang, Sunshin Kim, Joonghyun Ahn, 2009 .

Abstract P1-09-09: Role of endocrine therapy in premenopausal patients with hormone receptor-positive metastatic breast cancer, compared with postmenopausal patients: Diachronic analyses from nationwide cohort in Korea (KCSG BR 14-07)

J. Kim, Y. Im, S. Im, 2016 .